These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 18018772)

  • 1. High frequency of primary mutations associated with antiretroviral drug resistance in recently diagnosed HIV-infected children.
    Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Giraudi V; Ayala SG; Salomón H
    Antivir Ther; 2007; 12(7):1133-7. PubMed ID: 18018772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of minority populations of HIV type-1 with K103N and M184V drug resistance mutations among children in Argentina.
    Vignoles M; Barboni G; Agosti MR; Quarleri J; García MK; Ayala SG; Salomón H
    Antivir Ther; 2009; 14(8):1175-81. PubMed ID: 20032547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-retroviral drug resistance-associated mutations among non-subtype B HIV-1-infected Kenyan children with treatment failure.
    Lwembe R; Ochieng W; Panikulam A; Mongoina CO; Palakudy T; Koizumi Y; Kageyama S; Yamamoto N; Shioda T; Musoke R; Owens M; Songok EM; Okoth FA; Ichimura H
    J Med Virol; 2007 Jul; 79(7):865-72. PubMed ID: 17516531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance prevalence and HIV-1 variant characterization in the naive and pretreated HIV-1-infected paediatric population in Madrid, Spain.
    de Mulder M; Yebra G; Martín L; Prieto L; Mellado MJ; Rojo P; Muñoz-Fernández MÁ; Jiménez de Ory S; Ramos JT; Holguín A;
    J Antimicrob Chemother; 2011 Oct; 66(10):2362-71. PubMed ID: 21810838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of drug-resistance mutations in HIV-1 isolates from non-HAART and HAART treated patients in Burkina Faso.
    Nadembega WM; Giannella S; Simpore J; Ceccherini-Silberstein F; Pietra V; Bertoli A; Pignatelli S; Bellocchi MC; Nikiema JB; Cappelli G; Bere A; Colizzi V; Perno CP; Musumeci S
    J Med Virol; 2006 Nov; 78(11):1385-91. PubMed ID: 16998878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug resistance among chronic HIV-1-infected patients naïve for use of anti-retroviral therapy in Sao Paulo city.
    Gonsalez CR; Alcalde R; Nishiya A; Barreto CC; Silva FE; de Almeida A; Mendonça M; Ferreira F; Fernandes SS; Casseb J; Duarte AJ
    Virus Res; 2007 Nov; 129(2):87-90. PubMed ID: 17686543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
    AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient monitoring of HIV-1 vertically infected children in Kenya on first-line antiretroviral therapy.
    Lihana RW; Lwembe RM; Bi X; Ochieng W; Panikulam A; Palakudy T; Musoke R; Owens M; Ishizaki A; Okoth FA; Songok EM; Ichimura H
    J Clin Virol; 2011 Oct; 52(2):123-8. PubMed ID: 21798798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal.
    Palma AC; Araújo F; Duque V; Borges F; Paixão MT; Camacho R;
    Infect Genet Evol; 2007 Jun; 7(3):391-8. PubMed ID: 17360244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J; Pietra V; Pignatelli S; Karou D; Nadembega WM; Ilboudo D; Ceccherini-Silberstein F; Ghilat-Avoid-Belem WN; Bellocchi MC; Saleri N; Sanou MJ; Ouedraogo CM; Nikiema JB; Colizzi V; Perno CP; Castelli F; Musumeci S
    J Med Virol; 2007 Jul; 79(7):873-9. PubMed ID: 17516517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistant mutations detected by genotypic drug resistance testing in patients failing therapy in clade C HIV-1 infected individuals from India.
    Kandathil AJ; Kannangai R; Verghese VP; Pulimood SA; Rupali P; Sridharan G; Grant P; Pillay D; Abraham OC
    Indian J Med Microbiol; 2009; 27(3):231-6. PubMed ID: 19584504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-1 pol phylogenetic diversity and antiretroviral resistance mutations in treatment naïve patients from Central West Brazil.
    Cardoso LP; Queiroz BB; Stefani MM
    J Clin Virol; 2009 Oct; 46(2):134-9. PubMed ID: 19682948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 drug resistance mutations in children who failed non-nucleoside reverse transcriptase inhibitor-based antiretroviral therapy.
    Sungkanuparph S; Apiwattanakul N; Thitithanyanont A; Chantratita W; Sirinavin S
    Southeast Asian J Trop Med Public Health; 2009 Jan; 40(1):83-8. PubMed ID: 19323038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotypic drug resistance and long-term mortality in patients with triple-class antiretroviral drug failure.
    Lohse N; Jørgensen LB; Kronborg G; Møller A; Kvinesdal B; Sørensen HT; Obel N; Gerstoft J;
    Antivir Ther; 2007; 12(6):909-17. PubMed ID: 17926645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolving patterns of HIV-1 transmitted drug resistance in Poland in the years 2000-2008.
    Stańczak GP; Stańczak JJ; Marczyńska M; Firlag-Burkacka E; Wiercińska-Drapało A; Leszczyszyn-Pynka M; Jabłonowska E; Małolepsza E; Dyda T; Zabek P; Horban A
    J Med Virol; 2010 Jul; 82(7):1291-4. PubMed ID: 20513098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of primary antiretroviral resistance in Chilean patients recently infected with human immunodeficiency virus (HIV)].
    Acevedo W; Gallardo AM; Galaz J; Afani A; Cortés E
    Rev Med Chil; 2007 Nov; 135(11):1406-13. PubMed ID: 18259651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistance profiles after different periods of exposure to a first-line antiretroviral regimen in a Cameroonian cohort of HIV type-1-infected patients.
    Soria A; Porten K; Fampou-Toundji JC; Galli L; Mougnutou R; Buard V; Kfutwah A; Vessière A; Rousset D; Teck R; Calmy A; Ciaffi L; Lazzarin A; Gianotti N
    Antivir Ther; 2009; 14(3):339-47. PubMed ID: 19474468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profile of drug resistance mutations among HIV-1-infected Tunisian subjects failing antiretroviral therapy.
    Jlizi A; Ben Ammar El Gaaied A; Slim A; Tebourski F; Ben Mamou M; Ben Chaabane T; Letaief-Omezzine A; Chakroun M; Garbouj M; Ben Rejeb S
    Arch Virol; 2008; 153(6):1103-8. PubMed ID: 18483694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.